(Q38187680)

English

Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis

scientific article published on 31 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

0 references

Prognostic significance of Tet methylcytosine dioxygenase 2 (TET2) gene mutations in adult patients with acute myeloid leukemia: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Wen-Jian Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Xiao-Hong Tan

2

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Xiu-Ping Luo

3

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Bao-Ping Guo

4

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Zhou-Ji Wei

5

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Qing Ke

6

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Sha He

7

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Hong Cen

8

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

publication date

31 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

2691-2698

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

The role of mutations in epigenetic regulators in myeloid malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

DNMT3A mutation is a poor prognosis biomarker in AML: results of a meta-analysis of 4500 AML patients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Acquired mutations in TET2 are common in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Mutation in TET2 in myeloid cancers

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations in secondary acute myeloid leukemias: a French retrospective study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

The JAK2 rs12343867 CC genotype frequently occurs in patients with splanchnic venous thrombosis without the JAK2V617F mutation: a retrospective study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.893308

21 January 2018

Identifiers

10.3109/10428194.2014.893308

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38187680&oldid=1746238962"